-+ 0.00%
-+ 0.00%
-+ 0.00%

Annovis Bio Q3 EPS $(0.22) Beats $(0.32) Estimate

Benzinga·11/13/2026 13:09:03
Listen to the news
Annovis Bio (NYSE:ANVS) reported quarterly losses of $(0.22) per share which beat the analyst consensus estimate of $(0.32) by 31.25 percent. This is a 40.54 percent increase over losses of $(0.37) per share from the same period last year.